Clinical Trial

Assessment of Arrhythmic BuRdEn With Post-ProCedural COntinuous ElectRocarDiographic Monitoring in Patients Undergoing Transcatheter Aortic Valve Implantation: The RECORD Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
TAVI recipients exhibit a high burden of arrhythmic events early after the procedure. ECG continuous monitoring could be useful to diagnose and facilitate early implementation of specific therapeutic measures in these patients.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-03-05; most recent amendment 2026-03-23.
Status change: Recruiting → Active, Not Recruiting 2021-09-20
Trial Details
NCT Number NCT04298593
Lead Sponsor Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Conditions TAVI, ECG Monitoring
Enrollment 200 participants
Start Date 2019-06-28
Primary Completion 2021-12-31 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-27